Valacyclovir-Induced Thrombotic Thrombocytopenic Purpura

Valacyclovir is a well-tolerated antiviral drug. Thrombotic thrombocytopenic purpura is a rare adverse effect of valacyclovir therapy. Mostly, it has been reported in clinical trials and case reports in patients with high dose or low dose therapy in immunocompromised patients. Herein we write a case...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukhari, Sumera, Aslam, Hafiz M, Awwal, Talha A, Christmas, Donald, Wallach, Sara L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294875/
https://www.ncbi.nlm.nih.gov/pubmed/32550073
http://dx.doi.org/10.7759/cureus.8156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294875/
https://www.ncbi.nlm.nih.gov/pubmed/32550073
http://dx.doi.org/10.7759/cureus.8156

Ejemplares similares